Glimevel-M1 Tab

Composition

Glimepiride 1 mg + Metformin hydrochloride 500 mg (sustained/modified release)

Uses of Glimevel-M1 Tab

Type 2 diabetes mellitus (adult) when blood sugar is not adequately controlled with diet and exercise; used as add-on/combination therapy to improve glycaemic control

• •Lowers fasting and post-meal blood glucose
• •Improves insulin secretion and sensitivity
• •Helps achieve better HbA1c control than single therapy
• •Supports long-term diabetes control with diet and exercise

How it works

Glimepiride (a sulfonylurea) increases insulin release from pancreatic beta cells and improves peripheral insulin sensitivity. Metformin reduces glucose production by the liver and decreases intestinal glucose absorption while improving insulin sensitivity.

Directions for use

Take by mouth as prescribed, usually once daily with or just after meals (commonly breakfast) to reduce stomach upset and risk of low sugar. Swallow tablet whole; do not crush/chew if sustained/modified release. Follow diet/exercise plan and monitor blood glucose regularly.

Side effects

Common side effects of Glimevel-M1 Tab may include:

• •Hypoglycaemia (low blood sugar)
• •nausea
• •vomiting
• •diarrhoea
• •